Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06XSB
|
||||
Former ID |
DIB010315
|
||||
Drug Name |
870086 (topical, atopic dermatitis), GlaxoSmithKline
|
||||
Synonyms |
GW-870086-X (topical, atopic dermatitis), GlaxoSmithKline
|
||||
Indication | Atopic dermatitis [ICD9: 691.8, 692.9; ICD10:L00-L99] | Phase 2 | [1], [2] | ||
Company |
GlaxoSmithKline plc
|
||||
Target and Pathway | |||||
Target(s) | Glucocorticoid receptor | Target Info | Agonist | [3] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TCR Signaling Pathway | |||||
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Signaling events mediated by HDAC Class II | |||||
FOXA2 and FOXA3 transcription factor networks | |||||
Glucocorticoid receptor regulatory network | |||||
Regulation of Androgen receptor activity | |||||
AP-1 transcription factor network | |||||
Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
WikiPathways | Serotonin Receptor 4/6/7 and NR3C Signaling | ||||
SIDS Susceptibility Pathways | |||||
Nuclear Receptors Meta-Pathway | |||||
Endoderm Differentiation | |||||
Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||||
Adipogenesis | |||||
Circadian Clock | |||||
Nuclear Receptors | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT00549497) A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers. U.S. National Institutes of Health. | ||||
REF 2 | ClinicalTrials.gov (NCT01299610) A Study to Test the Effect of 2 Different Doses of Topical GW870086X on Atopic Dermatitis Also Including a Postive Control and a Placebo. U.S. National Institutes of Health. | ||||
REF 3 | Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):2100-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.